Global Syndromic Multiplex Diagnostics Market: COVID-19 Impact and Forecasts by Syndrome and Country | Point-of-Care Molecular Testing Unlocks Growth Opportunities

Syndromic multiplex diagnostics can lower costs, improve outcomes and combat Anti Microbial Resistance as Point of Care Testing and Molecular Diagnostics converge.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

Syndromic Multiplex Diagnostics Market 2025-2029: Global Forecasts by Syndrome, Testing Site, Product, and Country | Point-of-Care Molecular Testing Unlocks Strategic Growth

Point of Care Testing and Molecular Diagnostics are converging to streamline frontline testing, reduce costs and expand infectious disease testing into offices and homes.Dublin, Oct. 16, 2026 (GLOBE ...

Wissen Research LLC: Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen ResearchSheridan, WY, Oct. 15, 2026 /PRNewswire/ -- The global cancer diagnostics market is valued at USD 29.3 bil ...
The Scientist

Aptamer-Based Biosensors Offer a Faster Alternative to ELISA

Glint’s new proteomics technology enables fast and sensitive protein biomarker detection at a fraction of the cost of ...

Cancer Diagnostics Market to Reach US$ 41.5 Billion by 2031 at 7.2% CAGR, says Wissen Research

The global cancer diagnostics market is valued at USD 29.3 billion in 2026 and is projected to reach USD 41.5 billion by 2031, growing at a CAGR of 7.2% over the forecast period (2026–2031), according ...